These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27681288)

  • 21. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [MHC class II restricted antigen presentation].
    Hirata S; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():299-303. PubMed ID: 15861672
    [No Abstract]   [Full Text] [Related]  

  • 23. Exploring genome-wide datasets of MHC class II antigen presentation.
    Wijdeven RH; Bakker JM; Paul P; Neefjes J
    Mol Immunol; 2013 Sep; 55(2):172-4. PubMed ID: 23137594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells.
    Coulon PG; Richetta C; Rouers A; Blanchet FP; Urrutia A; Guerbois M; Piguet V; Theodorou I; Bet A; Schwartz O; Tangy F; Graff-Dubois S; Cardinaud S; Moris A
    J Immunol; 2016 Jul; 197(2):517-32. PubMed ID: 27288536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection.
    Mwangi W; Brown WC; Splitter GA; Zhuang Y; Kegerreis K; Palmer GH
    J Leukoc Biol; 2005 Aug; 78(2):401-11. PubMed ID: 15857936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic mechanisms of adaptive immunity emergence in vertebrates].
    Shilov ES; Kuprash DV
    Genetika; 2016 Jul; 52(7):761-73. PubMed ID: 29368839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells.
    Ishikawa R; Kajikawa M; Ishido S
    Int Immunol; 2014 May; 26(5):283-9. PubMed ID: 24370470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.
    Niazi KR; Ochoa MT; Sieling PA; Rooke NE; Peter AK; Mollahan P; Dickey M; Rabizadeh S; Rea TH; Modlin RL
    Immunology; 2007 Dec; 122(4):522-31. PubMed ID: 17635609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major histocompatibility complex (MHC) fragment numbers alone - in Atlantic cod and in general - do not represent functional variability.
    Dijkstra JM; Grimholt U
    F1000Res; 2018; 7():963. PubMed ID: 30135730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
    Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells.
    Tomazin R; Boname J; Hegde NR; Lewinsohn DM; Altschuler Y; Jones TR; Cresswell P; Nelson JA; Riddell SR; Johnson DC
    Nat Med; 1999 Sep; 5(9):1039-43. PubMed ID: 10470081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of major histocompatibility complex class II-associated invariant chain enhances the potency of an HIV gp120 DNA vaccine.
    Lu X; Wu S; Blackwell CE; Humphreys RE; von Hofe E; Xu M
    Immunology; 2007 Feb; 120(2):207-16. PubMed ID: 17116173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo.
    Xiang J; Moyana T
    Cancer Gene Ther; 1998; 5(5):313-20. PubMed ID: 9824051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization and MHC class II presentation of antigens targeted for macroautophagy.
    Schmid D; Münz C
    Methods Mol Biol; 2008; 445():213-25. PubMed ID: 18425453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MHC class II-presentation of antigen by autophagy].
    Kumamoto Y; Iwasaki A
    Tanpakushitsu Kakusan Koso; 2008 Dec; 53(16 Suppl):2286-91. PubMed ID: 21038623
    [No Abstract]   [Full Text] [Related]  

  • 37. Processing and major histocompatibility complex class II presentation of Legionella pneumophila antigens by infected macrophages.
    Neild A; Murata T; Roy CR
    Infect Immun; 2005 Apr; 73(4):2336-43. PubMed ID: 15784579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.
    Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS
    Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
    Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
    Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.